URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Edward Walsh

TitleProfessor
InstitutionSchool of Medicine and Dentistry
DepartmentMedicine
AddressUniversity of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 689
Rochester NY 14642
 
 Selected Publications
List All   |   Timeline
  1. Walsh EE, Shin JH, Falsey AR. Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations. J Infect Dis. 2013 Nov; 208(10):1634-42.
    View in: PubMed
  2. Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Baran A, Walsh EE. Bacterial complications of respiratory tract viral illness: a comprehensive evaluation. J Infect Dis. 2013 Aug; 208(3):432-41.
    View in: PubMed
  3. Mehta J, Walsh EE, Mahadevia PJ, Falsey AR. Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease. COPD. 2013 Jun; 10(3):293-9.
    View in: PubMed
  4. Walsh EE, Peterson DR, Kalkanoglu AE, Lee FE, Falsey AR. Viral shedding and immune responses to respiratory syncytial virus infection in older adults. J Infect Dis. 2013 May; 207(9):1424-32.
    View in: PubMed
  5. Morrison TG, Walsh EE. Subunit and virus-like particle vaccine approaches for respiratory syncytial virus. Curr Top Microbiol Immunol. 2013; 372:285-306.
    View in: PubMed
  6. Walsh EE, Swinburne AJ, Becker KL, Nylen ES, Snider RH, Baran A, Peterson DR, Falsey AR. Can serum procalcitonin levels help interpret indeterminate chest radiographs in patients hospitalized with acute respiratory illness? J Hosp Med. 2013 Feb; 8(2):61-7.
    View in: PubMed
  7. Gandhi A, Walsh EE, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Baran A, Falsey AR. Factors associated with symptomatic rhinovirus infection in patients with COPD. J Clin Virol. 2012 Dec; 55(4):343-7.
    View in: PubMed
  8. Falsey AR, Formica MA, Walsh EE. Simple method for combining sputum and nasal samples for virus detection by reverse transcriptase PCR. J Clin Microbiol. 2012 Aug; 50(8):2835.
    View in: PubMed
  9. Walsh EE, Falsey AR. Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets. 2012 Apr 1; 12(2):98-102.
    View in: PubMed
  10. Falsey AR, Becker KL, Swinburne AJ, Nylen ES, Snider RH, Formica MA, Hennessey PA, Criddle MM, Peterson DR, Walsh EE. Utility of serum procalcitonin values in patients with acute exacerbations of chronic obstructive pulmonary disease: a cautionary note. Int J Chron Obstruct Pulmon Dis. 2012; 7:127-35.
    View in: PubMed
  11. Walsh EE. Statins and influenza: can we move forward? J Infect Dis. 2012 Jan 1; 205(1):1-3.
    View in: PubMed
  12. Falsey AR, Formica MA, Walsh EE. Yield of sputum for viral detection by reverse transcriptase PCR in adults hospitalized with respiratory illness. J Clin Microbiol. 2012 Jan; 50(1):21-4.
    View in: PubMed
  13. Walsh EE. Respiratory syncytial virus infection in adults. Semin Respir Crit Care Med. 2011 Aug; 32(4):423-32.
    View in: PubMed
  14. Lee FE, Walsh EE, Falsey AR. The effect of steroid use in hospitalized adults with respiratory syncytial virus-related illness. Chest. 2011 Nov; 140(5):1155-61.
    View in: PubMed
  15. Lee FE, Halliley JL, Walsh EE, Moscatiello AP, Kmush BL, Falsey AR, Randall TD, Kaminiski DA, Miller RK, Sanz I. Circulating human antibody-secreting cells during vaccinations and respiratory viral infections are characterized by high specificity and lack of bystander effect. J Immunol. 2011 May 1; 186(9):5514-21.
    View in: PubMed
  16. Lee FE, Falsey AR, Halliley JL, Sanz I, Walsh EE. Circulating antibody-secreting cells during acute respiratory syncytial virus infection in adults. J Infect Dis. 2010 Dec 1; 202(11):1659-66.
    View in: PubMed
  17. Walsh EE, Greene L, Kirshner R. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery. Arch Intern Med. 2011 Jan 10; 171(1):68-73.
    View in: PubMed
  18. Murata Y, Lightfoote PM, Biear JN, Falsey AR, Walsh EE. Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein. Vaccine. 2010 Aug 31; 28(38):6242-6.
    View in: PubMed
  19. DeVincenzo J, Lambkin-Williams R, Wilkinson T, Cehelsky J, Nochur S, Walsh E, Meyers R, Gollob J, Vaishnaw A. A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus. Proc Natl Acad Sci U S A. 2010 May 11; 107(19):8800-5.
    View in: PubMed
  20. Halliley JL, Kyu S, Kobie JJ, Walsh EE, Falsey AR, Randall TD, Treanor J, Feng C, Sanz I, Lee FE. Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization. Vaccine. 2010 Apr 30; 28(20):3582-7.
    View in: PubMed
  21. Murata Y, Lightfoote PM, Falsey AR, Walsh EE. Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein. Clin Vaccine Immunol. 2010 Apr; 17(4):695-7.
    View in: PubMed
  22. Falsey AR, Hennessey PA, Formica MA, Criddle MM, Biear JM, Walsh EE. Humoral immunity to human metapneumovirus infection in adults. Vaccine. 2010 Feb 10; 28(6):1477-80.
    View in: PubMed
  23. Collarini EJ, Lee FE, Foord O, Park M, Sperinde G, Wu H, Harriman WD, Carroll SF, Ellsworth SL, Anderson LJ, Tripp RA, Walsh EE, Keyt BA, Kauvar LM. Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. J Immunol. 2009 Nov 15; 183(10):6338-45.
    View in: PubMed
  24. Duncan CB, Walsh EE, Peterson DR, Lee FE, Falsey AR. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J Infect Dis. 2009 Oct 15; 200(8):1242-6.
    View in: PubMed
  25. Falsey AR, Formica MA, Walsh EE. Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus. J Clin Virol. 2009 Dec; 46(4):314-7.
    View in: PubMed
  26. Kwilas S, Liesman RM, Zhang L, Walsh E, Pickles RJ, Peeples ME. Respiratory syncytial virus grown in Vero cells contains a truncated attachment protein that alters its infectivity and dependence on glycosaminoglycans. J Virol. 2009 Oct; 83(20):10710-8.
    View in: PubMed
  27. Murata Y, Lightfoote PM, Rose RC, Walsh EE. Antigenic presentation of heterologous epitopes engineered into the outer surface-exposed helix 4 loop region of human papillomavirus L1 capsomeres. Virol J. 2009; 6:81.
    View in: PubMed
  28. Walsh EE, Peterson DR, Falsey AR. Human metapneumovirus infections in adults: another piece of the puzzle. Arch Intern Med. 2008 Dec 8; 168(22):2489-96.
    View in: PubMed
  29. Falsey AR, Walsh EE, Capellan J, Gravenstein S, Zambon M, Yau E, Gorse GJ, Edelman R, Hayden FG, McElhaney JE, Neuzil KM, Nichol KL, Simões EA, Wright PF, Sales VM. Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals. J Infect Dis. 2008 Nov 1; 198(9):1317-26.
    View in: PubMed
  30. Lee FE, Walsh EE, Falsey AR, Lumb ME, Okam NV, Liu N, Divekar AA, Hall CB, Mosmann TR. Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection. J Infect Dis. 2007 Jun 15; 195(12):1779-88.
    View in: PubMed
  31. Lynch JP, Walsh EE. Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med. 2007 Apr; 28(2):144-58.
    View in: PubMed
  32. Murata Y, Walsh EE, Falsey AR. Pulmonary complications of interpandemic influenza A in hospitalized adults. J Infect Dis. 2007 Apr 1; 195(7):1029-37.
    View in: PubMed
  33. Walsh EE, Peterson DR, Falsey AR. Is clinical recognition of respiratory syncytial virus infection in hospitalized elderly and high-risk adults possible? J Infect Dis. 2007 Apr 1; 195(7):1046-51.
    View in: PubMed
  34. Falsey AR, Murata Y, Walsh EE. Impact of rapid diagnosis on management of adults hospitalized with influenza. Arch Intern Med. 2007 Feb 26; 167(4):354-60.
    View in: PubMed
  35. Ljubin Sternak S, Vilibic Cavlek T, Falsey AR, Walsh EE, Mlinaric Galinovic G. Serosurvey of human metapneumovirus infection in Croatia. Croat Med J. 2006 Dec; 47(6):878-81.
    View in: PubMed
  36. Falsey AR, Singh HK, Walsh EE. Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol. 2006 Nov; 78(11):1493-7.
    View in: PubMed
  37. Falsey AR, Walsh EE. Viral pneumonia in older adults. Clin Infect Dis. 2006 Feb 15; 42(4):518-24.
    View in: PubMed
  38. Falsey AR, Criddle MC, Walsh EE. Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness. J Clin Virol. 2006 Jan; 35(1):46-50.
    View in: PubMed
  39. Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Mar 15; 173(6):639-43.
    View in: PubMed
  40. Lee FE, Walsh EE, Falsey AR, Liu N, Liu D, Divekar A, Snyder-Cappione JE, Mosmann TR. The balance between influenza- and RSV-specific CD4 T cells secreting IL-10 or IFNgamma in young and healthy-elderly subjects. Mech Ageing Dev. 2005 Nov; 126(11):1223-9.
    View in: PubMed
  41. Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005 Apr 28; 352(17):1749-59.
    View in: PubMed
  42. Falsey AR, Walsh EE. Respiratory syncytial virus infection in elderly adults. Drugs Aging. 2005; 22(7):577-87.
    View in: PubMed
  43. Lee FE, Walsh EE, Falsey AR, Betts RF, Treanor JJ. Experimental infection of humans with A2 respiratory syncytial virus. Antiviral Res. 2004 Sep; 63(3):191-6.
    View in: PubMed
  44. Walsh EE, Falsey AR. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J Infect Dis. 2004 Jul 15; 190(2):373-8.
    View in: PubMed
  45. Walsh EE, Falsey AR. Age related differences in humoral immune response to respiratory syncytial virus infection in adults. J Med Virol. 2004 Jun; 73(2):295-9.
    View in: PubMed
  46. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004 Jan 15; 189(2):233-8.
    View in: PubMed
  47. Casiano-Colón AE, Hulbert BB, Mayer TK, Walsh EE, Falsey AR. Lack of sensitivity of rapid antigen tests for the diagnosis of respiratory syncytial virus infection in adults. J Clin Virol. 2003 Oct; 28(2):169-74.
    View in: PubMed
  48. Falsey AR, Formica MA, Treanor JJ, Walsh EE. Comparison of quantitative reverse transcription-PCR to viral culture for assessment of respiratory syncytial virus shedding. J Clin Microbiol. 2003 Sep; 41(9):4160-5.
    View in: PubMed
  49. Falsey AR, Walsh EE. Novel coronavirus and severe acute respiratory syndrome. Lancet. 2003 Apr 19; 361(9366):1312-3.
    View in: PubMed
  50. Falsey AR, Erdman D, Anderson LJ, Walsh EE. Human metapneumovirus infections in young and elderly adults. J Infect Dis. 2003 Mar 1; 187(5):785-90.
    View in: PubMed
  51. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002 Sep; 50(9):1498-503.
    View in: PubMed
  52. Falsey AR, Walsh EE, Hayden FG. Rhinovirus and coronavirus infection-associated hospitalizations among older adults. J Infect Dis. 2002 May 1; 185(9):1338-41.
    View in: PubMed
  53. Falsey AR, Formica MA, Walsh EE. Diagnosis of respiratory syncytial virus infection: comparison of reverse transcription-PCR to viral culture and serology in adults with respiratory illness. J Clin Microbiol. 2002 Mar; 40(3):817-20.
    View in: PubMed
  54. Looney RJ, Falsey AR, Walsh E, Campbell D. Effect of aging on cytokine production in response to respiratory syncytial virus infection. J Infect Dis. 2002 Mar 1; 185(5):682-5.
    View in: PubMed
  55. De Alarcon A, Walsh EE, Carper HT, La Russa JB, Evans BA, Rakes GP, Platts-Mills TA, Heymann PW. Detection of IgA and IgG but not IgE antibody to respiratory syncytial virus in nasal washes and sera from infants with wheezing. J Pediatr. 2001 Mar; 138(3):311-7.
    View in: PubMed
  56. Walsh EE, Falsey AR, Swinburne IA, Formica MA. Reverse transcription polymerase chain reaction (RT-PCR) for diagnosis of respiratory syncytial virus infection in adults: use of a single-tube "hanging droplet" nested PCR. J Med Virol. 2001 Mar; 63(3):259-63.
    View in: PubMed
  57. Falsey AR, Walsh EE, Francis CW, Looney RJ, Kolassa JE, Hall WJ, Abraham GN. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J Infect Dis. 2001 Apr 1; 183(7):995-9.
    View in: PubMed
  58. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000 Nov; 1(5):398-401.
    View in: PubMed
  59. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000 Jul; 13(3):371-84.
    View in: PubMed
  60. Gonzalez IM, Karron RA, Eichelberger M, Walsh EE, Delagarza VW, Bennett R, Chanock RM, Murphy BR, Clements-Mann ML, Falsey AR. Evaluation of the live attenuated cpts 248/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults. Vaccine. 2000 Mar 6; 18(17):1763-72.
    View in: PubMed
  61. Falsey AR, Walsh EE, Looney RJ, Kolassa JE, Formica MA, Criddle MC, Hall WJ. Comparison of respiratory syncytial virus humoral immunity and response to infection in young and elderly adults. J Med Virol. 1999 Oct; 59(2):221-6.
    View in: PubMed
  62. Walsh EE, Falsey AR, Hennessey PA. Respiratory syncytial and other virus infections in persons with chronic cardiopulmonary disease. Am J Respir Crit Care Med. 1999 Sep; 160(3):791-5.
    View in: PubMed
  63. Chamat S, Walsh EE, Anderson D, Osta M, Awaraji C, Pan LZ, Ochi J, Shuey S, Brams P. Human monoclonal antibodies isolated from spontaneous Epstein-Barr virus-transformed tumors of Hu-SPL-SCID mice and specific for fusion protein display broad neutralizing activity toward respiratory syncytial virus. J Infect Dis. 1999 Aug; 180(2):268-77.
    View in: PubMed
  64. Walsh EE, Falsey AR. A simple and reproducible method for collecting nasal secretions in frail elderly adults, for measurement of virus-specific IgA. J Infect Dis. 1999 May; 179(5):1268-73.
    View in: PubMed
  65. Walsh EE, Falsey AR, Sullender WM. Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein. J Gen Virol. 1998 Mar; 79 ( Pt 3):479-87.
    View in: PubMed
  66. Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis. 1998 Feb; 177(2):463-6.
    View in: PubMed
  67. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in the institutionalized elderly. Vaccine. 1997 Jul; 15(10):1130-2.
    View in: PubMed
  68. Walsh EE, McConnochie KM, Long CE, Hall CB. Severity of respiratory syncytial virus infection is related to virus strain. J Infect Dis. 1997 Apr; 175(4):814-20.
    View in: PubMed
  69. Mlinaric-Galinovic G, Falsey AR, Walsh EE. Respiratory syncytial virus infection in the elderly. Eur J Clin Microbiol Infect Dis. 1996 Oct; 15(10):777-81.
    View in: PubMed
  70. Falsey AR, Walsh EE. Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60. Vaccine. 1996 Sep; 14(13):1214-8.
    View in: PubMed
  71. Walsh EE. Humoral, mucosal, and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine. J Infect Dis. 1994 Aug; 170(2):345-50.
    View in: PubMed
  72. Siber GR, Leombruno D, Leszczynski J, McIver J, Bodkin D, Gonin R, Thompson CM, Walsh EE, Piedra PA, Hemming VG, et al. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis. 1994 Jun; 169(6):1368-73.
    View in: PubMed
  73. Oien NL, Brideau RJ, Walsh EE, Wathen MW. Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit. Vaccine. 1994 Jun; 12(8):731-5.
    View in: PubMed
  74. Belshe RB, Anderson EL, Walsh EE. Immunogenicity of purified F glycoprotein of respiratory syncytial virus: clinical and immune responses to subsequent natural infection in children. J Infect Dis. 1993 Oct; 168(4):1024-9.
    View in: PubMed
  75. Falsey AR, Walsh EE. Transmission of Chlamydia pneumoniae. J Infect Dis. 1993 Aug; 168(2):493-6.
    View in: PubMed
  76. Walsh EE. Mucosal immunization with a subunit respiratory syncytial virus vaccine in mice. Vaccine. 1993; 11(11):1135-8.
    View in: PubMed
  77. Siber GR, Leszcynski J, Pena-Cruz V, Ferren-Gardner C, Anderson R, Hemming VG, Walsh EE, Burns J, McIntosh K, Gonin R, et al. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis. 1992 Mar; 165(3):456-63.
    View in: PubMed
  78. Falsey AR, Treanor JJ, Betts RF, Walsh EE. Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings. J Am Geriatr Soc. 1992 Feb; 40(2):115-9.
    View in: PubMed
  79. Falsey AR, Walsh EE. Humoral immunity to respiratory syncytial virus infection in the elderly. J Med Virol. 1992 Jan; 36(1):39-43.
    View in: PubMed
  80. Muelenaer PM, Henderson FW, Hemming VG, Walsh EE, Anderson LJ, Prince GA, Murphy BR. Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections. J Infect Dis. 1991 Jul; 164(1):15-21.
    View in: PubMed
  81. Hall CB, Walsh EE, Long CE, Schnabel KC. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis. 1991 Apr; 163(4):693-8.
    View in: PubMed
  82. Salkind AR, McCarthy DO, Nichols JE, Domurat FM, Walsh EE, Roberts NJ. Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses. J Infect Dis. 1991 Jan; 163(1):71-7.
    View in: PubMed
  83. Hall CB, Walsh EE, Schnabel KC, Long CE, McConnochie KM, Hildreth SW, Anderson LJ. Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children. J Infect Dis. 1990 Dec; 162(6):1283-90.
    View in: PubMed
  84. Falsey AR, Walsh EE, Betts RF. Serologic evidence of respiratory syncytial virus infection in nursing home patients. J Infect Dis. 1990 Aug; 162(2):568-9.
    View in: PubMed
  85. McConnochie KM, Hall CB, Walsh EE, Roghmann KJ. Variation in severity of respiratory syncytial virus infections with subtype. J Pediatr. 1990 Jul; 117(1 Pt 1):52-62.
    View in: PubMed
  86. Brandriss MW, Schlesinger JJ, Walsh EE. Immunogenicity of a purified fragment of 17D yellow fever envelope protein. J Infect Dis. 1990 Jun; 161(6):1134-9.
    View in: PubMed
  87. Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE. Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. J Gen Virol. 1990 Mar; 71 ( Pt 3):593-9.
    View in: PubMed
  88. Walsh EE, Hall CB, Schlesinger JJ, Brandriss MW, Hildreth S, Paradiso P. Comparison of antigenic sites of subtype-specific respiratory syncytial virus attachment proteins. J Gen Virol. 1989 Nov; 70 ( Pt 11):2953-61.
    View in: PubMed
  89. Wagner DK, Muelenaer P, Henderson FW, Snyder MH, Reimer CB, Walsh EE, Anderson LJ, Nelson DL, Murphy BR. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second, and third infections. J Clin Microbiol. 1989 Mar; 27(3):589-92.
    View in: PubMed
  90. Murphy BR, Walsh EE. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol. 1988 Aug; 26(8):1595-7.
    View in: PubMed
  91. Hendry RM, Burns JC, Walsh EE, Graham BS, Wright PF, Hemming VG, Rodriguez WJ, Kim HW, Prince GA, McIntosh K, et al. Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis. 1988 Apr; 157(4):640-7.
    View in: PubMed
  92. Johnson PR, Olmsted RA, Prince GA, Murphy BR, Alling DW, Walsh EE, Collins PL. Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity. J Virol. 1987 Oct; 61(10):3163-6.
    View in: PubMed
  93. Walsh EE, Brandriss MW, Schlesinger JJ. Immunological differences between the envelope glycoproteins of two strains of human respiratory syncytial virus. J Gen Virol. 1987 Aug; 68 ( Pt 8):2169-76.
    View in: PubMed
  94. Walsh EE, Hall CB, Briselli M, Brandriss MW, Schlesinger JJ. Immunization with glycoprotein subunits of respiratory syncytial virus to protect cotton rats against viral infection. J Infect Dis. 1987 Jun; 155(6):1198-204.
    View in: PubMed
  95. Wagner DK, Nelson DL, Walsh EE, Reimer CB, Henderson FW, Murphy BR. Differential immunoglobulin G subclass antibody titers to respiratory syncytial virus F and G glycoproteins in adults. J Clin Microbiol. 1987 Apr; 25(4):748-50.
    View in: PubMed
  96. Mock DJ, Domurat F, Roberts NJ, Walsh EE, Licht MR, Keng P. Macrophages are required for influenza virus infection of human lymphocytes. J Clin Invest. 1987 Feb; 79(2):620-4.
    View in: PubMed
  97. Kasel JA, Walsh EE, Frank AL, Baxter BD, Taber LH, Glezen WP. Relation of serum antibody to glycoproteins of respiratory syncytial virus with immunity to infection in children. Viral Immunol. 1987-1988; 1(3):199-205.
    View in: PubMed
  98. Murphy BR, Alling DW, Snyder MH, Walsh EE, Prince GA, Chanock RM, Hemming VG, Rodriguez WJ, Kim HW, Graham BS, et al. Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection. J Clin Microbiol. 1986 Nov; 24(5):894-8.
    View in: PubMed
  99. Murphy BR, Prince GA, Walsh EE, Kim HW, Parrott RH, Hemming VG, Rodriguez WJ, Chanock RM. Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine. J Clin Microbiol. 1986 Aug; 24(2):197-202.
    View in: PubMed
  100. Wagner DK, Graham BS, Wright PF, Walsh EE, Kim HW, Reimer CB, Nelson DL, Chanock RM, Murphy BR. Serum immunoglobulin G antibody subclass responses to respiratory syncytial virus F and G glycoproteins after primary infection. J Clin Microbiol. 1986 Aug; 24(2):304-6.
    View in: PubMed
  101. Murphy BR, Graham BS, Prince GA, Walsh EE, Chanock RM, Karzon DT, Wright PF. Serum and nasal-wash immunoglobulin G and A antibody response of infants and children to respiratory syncytial virus F and G glycoproteins following primary infection. J Clin Microbiol. 1986 Jun; 23(6):1009-14.
    View in: PubMed
  102. Walsh EE, Cote PJ, Fernie BF, Schlesinger JJ, Brandriss MW. Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies. J Gen Virol. 1986 Mar; 67 ( Pt 3):505-13.
    View in: PubMed
  103. Prince GA, Jenson AB, Hemming VG, Murphy BR, Walsh EE, Horswood RL, Chanock RM. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus. J Virol. 1986 Mar; 57(3):721-8.
    View in: PubMed
  104. Domurat F, Roberts NJ, Walsh EE, Dagan R. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo. J Infect Dis. 1985 Nov; 152(5):895-902.
    View in: PubMed
  105. Hemming VG, Prince GA, Horswood RL, London WJ, Murphy BR, Walsh EE, Fischer GW, Weisman LE, Baron PA, Chanock RM. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model. J Infect Dis. 1985 Nov; 152(5):1083-7.
    View in: PubMed
  106. Schlesinger JJ, Brandriss MW, Walsh EE. Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol. 1985 Oct; 135(4):2805-9.
    View in: PubMed
  107. Walsh EE, Brandriss MW, Schlesinger JJ. Purification and characterization of the respiratory syncytial virus fusion protein. J Gen Virol. 1985 Mar; 66 ( Pt 3):409-15.
    View in: PubMed
  108. Walsh EE, Schlesinger JJ, Brandriss MW. Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. J Gen Virol. 1984 Apr; 65 ( Pt 4):761-7.
    View in: PubMed
  109. Walsh EE, Schlesinger JJ, Brandriss MW. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect Immun. 1984 Feb; 43(2):756-8.
    View in: PubMed
  110. Walsh EE, Hruska J. Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion protein. J Virol. 1983 Jul; 47(1):171-7.
    View in: PubMed
  111. Hall CB, McBride JT, Walsh EE, Bell DM, Gala CL, Hildreth S, Ten Eyck LG, Hall WJ. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med. 1983 Jun 16; 308(24):1443-7.
    View in: PubMed
  112. Bell DM, Walsh EE, Hruska JF, Schnabel KC, Hall CB. Rapid detection of respiratory syncytial virus with a monoclonal antibody. J Clin Microbiol. 1983 Jun; 17(6):1099-101.
    View in: PubMed
  113. Hall CB, Walsh EE, Hruska JF, Betts RF, Hall WJ. Ribavirin treatment of experimental respiratory syncytial viral infection. A controlled double-blind study in young adults. JAMA. 1983 May 20; 249(19):2666-70.
    View in: PubMed
  114. Walsh EE, Hruska JF. Identification of the virus-specific proteins of respiratory syncytial virus temperature-sensitive mutants by immunoprecipitation. Proc Soc Exp Biol Med. 1983 Feb; 172(2):202-6.
    View in: PubMed

Visualizations


Walsh's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department